DiscoverTalking the Cure by Hogan LovellsTalking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)
Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)

Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)

Update: 2023-09-28
Share

Description

In this podcast episode, Alice Curran and Cullen Taylor discuss the implications of the Inflation Reduction Act (IRA) on the life sciences and healthcare sector. They explore how IRA can impact drug pricing, development, collaboration, and partnerships. The episode covers assessing IRA’s impact, economic provisions in agreements, launch strategies, backup compounds, fixed-dose combinations, and the challenges of out-licensing. They highlight the complexities and potential risks in dealing with IRA.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)

Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)

Hogan Lovells